|
1
|
Fukui H, Saito H, Ueno Y, Uto H, Obara K,
Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, et al:
Evidence-based clinical practice guidelines for liver cirrhosis
2015. J Gastroenterol. 51:629–650. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancela E, Ministro P, Peixoto P, Sadio A,
Castanheira A, Silva A and Caldas A: Concomitant life threatening
lesions in a cirrhotic patient: The value of endoscopic treatment.
Rev Esp Enferm Dig. 102:617–618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abid S, Jafri W, Hamid S, Salih M, Azam Z,
Mumtaz K, Shah HA and Abbas Z: Terlipressin vs. octreotide in
bleeding esophageal varices as an adjuvant therapy with endoscopic
band ligation: A randomized double-blind placebo-controlled trial.
Am J Gastroenterol. 104:617–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Escorsell À, Pavel O, Cárdenas A, Morillas
R, Llop E, Villanueva C, Garcia-Pagán JC and Bosch J; Variceal
Bleeding Study Group, : Esophageal balloon tamponade versus
esophageal stent in controlling acute refractory variceal bleeding:
A multicenter randomized, controlled trial. Hepatology.
63:1957–1967. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Drastich P, Lata J, Petrtyl J, Bruha R,
Prochazka V, Vanasek T, Zdenek P, Skibova J, Hucl T and Spicak J:
Endoscopic variceal band ligation compared with propranolol for
prophylaxis of first variceal bleeding. Ann Hepatol. 10:142–149.
2011.PubMed/NCBI
|
|
6
|
D'Amico G, Pietrosi G, Tarantino I and
Pagliaro L: Emergency sclerotherapy versus vasoactive drugs for
variceal bleeding in cirrhosis: A Cochrane meta-analysis.
Gastroenterology. 124:1277–1291. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garbuzenko DV: Current approaches to the
management of patients with liver cirrhosis who have acute
esophageal variceal bleeding. Curr Med Res Opin. 32:467–475. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Crean S, Michels SL, Moschella K and
Reynolds MW: Bovine thrombin safety reporting: An example of study
design and publication bias. J Surg Res. 158:77–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ballard JL, Weaver FA, Singla NK, Chapman
WC and Alexander WA: Safety and immunogenicity observations pooled
from eight clinical trials of recombinant human thrombin. J Am Coll
Surg. 210:199–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ludwig D, Schädel S, Brüning A, Schiefer B
and Stange EF: 48-hour hemodynamic effects of octreotide on
postprandial splanchnic hyperemia in patients with liver cirrhosis
and portal hypertension: Double-blind, placebo-controlled study.
Dig Dis Sci. 45:1019–1027. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chaireti R, Rajani R, Bergquist A, Melin
T, Friis-Liby IL, Kapraali M, Kechagias S, Lindahl TL and Almer S:
Increased thrombin generation in splanchnic vein thrombosis is
related to the presence of liver cirrhosis and not to the
thrombotic event. Thromb Res. 134:455–461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanai M, Hamada A, Endo Y, Takeda Y,
Yamakawa M, Nishikawa H and Torii A: Efficacy of argon plasma
coagulation in nonvariceal upper gastrointestinal bleeding.
Endoscopy. 36:1085–1088. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boonstra AM, Schiphorst Preuper HR, Balk
GA and Stewart RE: Cut-off points for mild, moderate, and severe
pain on the visual analogue scale for pain in patients with chronic
musculoskeletal pain. Pain. 155:2545–2550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ge PS and Runyon BA: Treatment of patients
with cirrhosis. N Engl J Med. 375:767–777. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Liu W, Chen YH, Fan CL, Dong PL, Wei
FL, Li B, Chen DX and Ding HG: Antiviral drug resistance increases
hepatocellular carcinoma: A prospective decompensated cirrhosis
cohort study. World J Gastroenterol. 19:8373–8381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo LH and Xu HX: Contrast-enhanced
ultrasound in the diagnosis of hepatocellular carcinoma and
intrahepatic cholangiocarcinoma: Controversy over the ASSLD
guideline. BioMed Res Int. 2015:3491722015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schuppan D and Afdhal NH: Liver cirrhosis.
Lancet. 371:838–851. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou D, Qi X, Zhu C, Ning Z, Hou F, Zhao J,
Peng Y, Li J, Deng H and Guo X: Albumin-bilirubin score for
predicting the in-hospital mortality of acute upper
gastrointestinal bleeding in liver cirrhosis: A retrospective
study. Turk J Gastroenterol. 27:180–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Romcea AA, Tanţău M, Seicean A and Pascu
O: The etiology of upper gastrointestinal bleeding in cirrhotic
patients. Clujul Med. 86:21–23. 2013.PubMed/NCBI
|
|
20
|
Lyles T, Elliott A and Rockey DC: A risk
scoring system to predict in-hospital mortality in patients with
cirrhosis presenting with upper gastrointestinal bleeding. J Clin
Gastroenterol. 48:712–720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tripathi D, Stanley AJ, Hayes PC, Patch D,
Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M,
et al Clinical Services and Standards Committee of the British
Society of Gastroenterology, : U.K. guidelines on the management of
variceal haemorrhage in cirrhotic patients. Gut. 64:1680–1704.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
DeLaney M and Greene CJ: Emergency
department evaluation and management of patients with upper
gastrointestinal bleeding. Emerg Med Pract. 17:1–19.
2015.PubMed/NCBI
|
|
23
|
Mocarzel LO, Bicca J, Jarske L, Oliveira
T, Lanzieri P, Gismondi R and Ribeiro ML: Cirrhotic cardiomyopathy:
Another case of a successful approach to treatment of hepatorenal
syndrome. Case Rep Gastroenterol. 10:531–537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou DX, Zhou HB, Wang Q, Zou SS, Wang H
and Hu HP: The effectiveness of the treatment of octreotide on
chylous ascites after liver cirrhosis. Dig Dis Sci. 54:1783–1788.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu X, Tian P, Xu GJ, Sun XL and Ma XL:
Thrombin-based hemostatic agent in primary total knee arthroplasty.
J Knee Surg. 30:121–127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Friedlander TW, Weinberg VK, Small EJ,
Sharib J, Harzstark AL, Lin AM, Fong L and Ryan CJ: Effect of the
somatostatin analog octreotide acetate on circulating insulin-like
growth factor-1 and related peptides in patients with
non-metastatic castration-resistant prostate cancer: Results of a
phase II study. Urol Oncol. 30:408–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SH, Oh EG and Lee WH: Symptom
experience, psychological distress, and quality of life in Korean
patients with liver cirrhosis: A cross-sectional survey. Int J Nurs
Stud. 43:1047–1056. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang F, Xiang ML and Liu YM: Thrombin in
combination with intensive nursing in treating upper
gastrointestinal bleeding in children. J Biol Regul Homeost Agents.
30:491–495. 2016.PubMed/NCBI
|
